Skip to main content

Silexion Therapeutics Corp 8-K, filed Nov 9, 2026

Silexion Therapeutics Corp (SLXN)

8-K 2026-11-09 For: 2026-11-09
View Original
Added on November 09, 2026

About this 8-K

Silexion Therapeutics Corp filed this 8-K on November 9, 2026.

Silexion Therapeutics Corp will conduct a 1-for-24 reverse share split after market close on November 10, 2026, with split-adjusted Nasdaq Capital Market trading beginning November 11, 2026 under ticker “SLXN”; par value will rise from $0.135 per share to $3.24 per share. AI summary

Items reported

  • Item 8.01: Other events
  • Item 9.01: Financial statements and exhibits